ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $24,000 | -31.4% | 6,877 | +100.6% | 0.00% | -50.0% |
Q1 2021 | $35,000 | +191.7% | 3,428 | +187.6% | 0.00% | +100.0% |
Q3 2020 | $12,000 | -80.6% | 1,192 | -59.6% | 0.00% | -75.0% |
Q2 2020 | $62,000 | +287.5% | 2,947 | +79.8% | 0.00% | +300.0% |
Q1 2020 | $16,000 | +14.3% | 1,639 | +46.1% | 0.00% | 0.0% |
Q4 2019 | $14,000 | 0.0% | 1,122 | -57.3% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -89.0% | 2,629 | -75.4% | 0.00% | -88.9% |
Q2 2019 | $127,000 | +958.3% | 10,694 | +372.1% | 0.01% | +800.0% |
Q1 2019 | $12,000 | +33.3% | 2,265 | -24.4% | 0.00% | 0.0% |
Q4 2018 | $9,000 | +200.0% | 2,997 | +532.3% | 0.00% | – |
Q3 2018 | $3,000 | -40.0% | 474 | -69.3% | 0.00% | – |
Q4 2017 | $5,000 | -16.7% | 1,546 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $6,000 | +50.0% | 1,546 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | 0.0% | 1,546 | 0.0% | 0.00% | – |
Q1 2017 | $4,000 | -66.7% | 1,546 | -62.0% | 0.00% | -100.0% |
Q4 2016 | $12,000 | – | 4,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |